Journal of Cancer Research and Therapeutics Close
 

Figure 3: The pancreas histology in control, cisplatin, and cisplatin + oleuropein group rats, (a) Control group, (b) The decreased glycogen content in pancreas of cisplatin group compared with control group, (c and d) The increased glycogen content in pancreas of cisplatin + 50 mg/kg and cisplatin + 100 mg/kg oleuropein groups, (e) The glycogen content in pancreas of cisplatin + 200 mg/kg oleuropein group similar to control (PAS, ×200)

Figure 3: The pancreas histology in control, cisplatin, and cisplatin + oleuropein group rats, (a) Control group, (b) The decreased glycogen content in pancreas of cisplatin group compared with control group, (c and d) The increased glycogen content in pancreas of cisplatin + 50 mg/kg and cisplatin + 100 mg/kg oleuropein groups, (e) The glycogen content in pancreas of cisplatin + 200 mg/kg oleuropein group similar to control (PAS, ×200)